For: | Thomas EL, Brynes AE, Hamilton G, Patel N, Spong A, Goldin RD, Frost G, Bell JD, Taylor-Robinson SD. Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease. World J Gastroenterol 2006; 12(36): 5813-5819 [PMID: 17007047 DOI: 10.3748/wjg.v12.i36.5813] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i36/5813.htm |
Number | Citing Articles |
1 |
Stefano Bellentani, Riccardo Dalle Grave, Alessandro Suppini, Giulio Marchesini. Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach. Hepatology 2008; 47(2): 746 doi: 10.1002/hep.22009
|
2 |
Kittichai Promrat, David E. Kleiner, Heather M. Niemeier, Elizabeth Jackvony, Marie Kearns, Jack R. Wands, Joseph L. Fava, Rena R. Wing. Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis. Hepatology 2010; 51(1): 121 doi: 10.1002/hep.23276
|
3 |
Sunil Daniel, Taraneh Soleymani, W. Timothy Garvey. A complications-based clinical staging of obesity to guide treatment modality and intensity. Current Opinion in Endocrinology, Diabetes & Obesity 2013; 20(5): 377 doi: 10.1097/01.med.0000433067.01671.f5
|
4 |
Mariana Lazo, Steven F. Solga, Alena Horska, Susanne Bonekamp, Anna Mae Diehl, Frederick L. Brancati, Lynne E. Wagenknecht, F. Xavier Pi-Sunyer, Steven E. Kahn, Jeanne M. Clark. Effect of a 12-Month Intensive Lifestyle Intervention on Hepatic Steatosis in Adults With Type 2 Diabetes. Diabetes Care 2010; 33(10): 2156 doi: 10.2337/dc10-0856
|
5 |
Mariangela Rondanelli, Clara Gasparri, Claudia Razza, Cinzia Ferraris, Simone Perna, Ilaria Ferrarotti, Angelo Guido Corsico. Practical dietary advices for subjects with alpha-1 antitrypsin deficiency. Biomedicine & Pharmacotherapy 2023; 163: 114753 doi: 10.1016/j.biopha.2023.114753
|
6 |
Rick A Vreman, Alex J Goodell, Luis A Rodriguez, Travis C Porco, Robert H Lustig, James G Kahn. Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model. BMJ Open 2017; 7(8): e013543 doi: 10.1136/bmjopen-2016-013543
|
7 |
Brian Lam, Zobair M. Younossi. Review: Treatment options for nonalcoholic fatty liver disease. Therapeutic Advances in Gastroenterology 2010; 3(2): 121 doi: 10.1177/1756283X09359964
|
8 |
Naga Chalasani, Zobair Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142(7): 1592 doi: 10.1053/j.gastro.2012.04.001
|
9 |
Sven Haufe, Verena Haas, Wolfgang Utz, Andreas L. Birkenfeld, Stephanie Jeran, Jana Böhnke, Anja Mähler, Friedrich C. Luft, Jeanette Schulz-Menger, Michael Boschmann, Jens Jordan, Stefan Engeli. Long-Lasting Improvements in Liver Fat and Metabolism Despite Body Weight Regain After Dietary Weight Loss. Diabetes Care 2013; 36(11): 3786 doi: 10.2337/dc13-0102
|
10 |
Stephan C. Bischoff, William Bernal, Srinivasan Dasarathy, Manuela Merli, Lindsay D. Plank, Tatjana Schütz, Mathias Plauth. ESPEN practical guideline: Clinical nutrition in liver disease. Clinical Nutrition 2020; 39(12): 3533 doi: 10.1016/j.clnu.2020.09.001
|
11 |
Mathias Plauth, Lars Bechmann, Donata Grajecki, Felix Gundling, Ludwig Kramer, Andreas E. Kremer, Monika Rau, Andrea Schneider, Frank Tacke, Ingo van Thiel. S2k-Leitlinie Klinische Ernährung in der Hepatologie. Aktuelle Ernährungsmedizin 2024; 49(04): 256 doi: 10.1055/a-2338-1144
|
12 |
Shi-Ming Chen, Chieh-Yu Liu, Shian-Rei Li, Hui-Ting Huang, Ching-Yen Tsai, Hei-Jen Jou. Effects of Therapeutic Lifestyle Program on Ultrasound-diagnosed Nonalcoholic Fatty Liver Disease. Journal of the Chinese Medical Association 2008; 71(11): 551 doi: 10.1016/S1726-4901(08)70168-0
|
13 |
Pinar Hamurcu Varol, Eda Kaya, Emel Alphan, Yusuf Yilmaz. Role of intensive dietary and lifestyle interventions in the treatment of lean nonalcoholic fatty liver disease patients. European Journal of Gastroenterology & Hepatology 2020; 32(10): 1352 doi: 10.1097/MEG.0000000000001656
|
14 |
Sameer M. Mazhar, Masoud Shiehmorteza, Claude B. Sirlin. Noninvasive Assessment of Hepatic Steatosis. Clinical Gastroenterology and Hepatology 2009; 7(2): 135 doi: 10.1016/j.cgh.2008.11.023
|
15 |
Mathias Plauth. Comprehensive Guide to Hepatitis Advances. 2023; : 87 doi: 10.1016/B978-0-323-98368-6.00004-5
|
16 |
Elisa Fabbrini, Caterina Conte, Faidon Magkos. Methods for assessing intrahepatic fat content and steatosis. Current Opinion in Clinical Nutrition & Metabolic Care 2009; 12(5): 474 doi: 10.1097/MCO.0b013e32832eb587
|
17 |
Naga Chalasani, Zobair Younossi, Joel E Lavine, Anna Mae Diehl, Elizabeth M Brunt, Kenneth Cusi, Michael Charlton, Arun J Sanyal. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. American Journal of Gastroenterology 2012; 107(6): 811 doi: 10.1038/ajg.2012.128
|
18 |
Roy J. Shephard, Nathan Johnson. Effects of physical activity upon the liver. European Journal of Applied Physiology 2015; 115(1): 1 doi: 10.1007/s00421-014-3031-6
|
19 |
Raj Shah, Sagarika Satyavada, Perica Davitkov. Nutrition, Weight, and Digestive Health. 2022; : 107 doi: 10.1007/978-3-030-94953-2_7
|
20 |
Scott McNear, Stephen A. Harrison. Review: Current status of therapy in nonalcoholic fatty liver disease. Therapeutic Advances in Gastroenterology 2009; 2(1): 29 doi: 10.1177/1756283X08100327
|
21 |
Naga Chalasani, Zobair Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55(6): 2005 doi: 10.1002/hep.25762
|
22 |
Somayyeh Asghari, Mohammad Asghari-Jafarabadi, Mohammad-Hossein Somi, Seyed-Mostafa Ghavami, Maryam Rafraf. Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial. Journal of the American College of Nutrition 2018; 37(3): 223 doi: 10.1080/07315724.2017.1392264
|
23 |
Guillaume Henin, Audrey Loumaye, Louise Deldicque, Isabelle A. Leclercq, Nicolas Lanthier. Unlocking liver health: Can tackling myosteatosis spark remission in metabolic dysfunction‐associated steatotic liver disease?. Liver International 2024; 44(8): 1781 doi: 10.1111/liv.15938
|
24 |
Waleed Salah El-din Mahmoud, Ahmed Yousef, E Manssor, Sameh Ahmed. The relationship between pain and functional disability with morphological changes of psoas major in discogenic low back pain patients. International Journal of Therapy and Rehabilitation 2016; 23(8): 363 doi: 10.12968/ijtr.2016.23.8.363
|
25 |
Henry L‐Y Chan, H Janaka De Silva, Nancy W‐Y Leung, Seng‐Gee Lim, Geoffrey C Farrell. How should we manage patients with non‐alcoholic fatty liver disease in 2007?. Journal of Gastroenterology and Hepatology 2007; 22(6): 801 doi: 10.1111/j.1440-1746.2007.04977.x
|
26 |
Francesca M Trovato, Giuseppe Fabio Martines, Daniela Brischetto, Guglielmo Trovato, Daniela Catalano. Neglected features of lifestyle: Their relevance in non-alcoholic fatty liver disease. World Journal of Hepatology 2016; 8(33): 1459-1465 doi: 10.4254/wjh.v8.i33.1459
|
27 |
Jean-François Dufour. NASH and thiazolidinediones: Not to be taken lightly. Journal of Hepatology 2007; 47(4): 451 doi: 10.1016/j.jhep.2007.07.012
|
28 |
Nina F. Schwenzer, Fabian Springer, Christina Schraml, Norbert Stefan, Jürgen Machann, Fritz Schick. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. Journal of Hepatology 2009; 51(3): 433 doi: 10.1016/j.jhep.2009.05.023
|
29 |
Shelby Sullivan, Erik P. Kirk, Bettina Mittendorfer, Bruce W. Patterson, Samuel Klein. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology 2012; 55(6): 1738 doi: 10.1002/hep.25548
|
30 |
Andriana C. Kaliora, Alexander Kokkinos, Anastacia Diolintzi, Maria Stoupaki, Aristea Gioxari, Panagiotis T. Kanellos, George V. Z. Dedoussis, Jiannis Vlachogiannakos, Constantinos Revenas, Spiros D. Ladas, Vaios T. Karathanos. The effect of minimal dietary changes with raisins in NAFLD patients with non-significant fibrosis: a randomized controlled intervention. Food & Function 2016; 7(11): 4533 doi: 10.1039/C6FO01040G
|
31 |
Zifeng Yang, Shiqiang Sun, Yuanli Chen, Rui Li. Application of Single Voxel 1H Magnetic Resonance Spectroscopy in Hepatic Benign and Malignant Lesions. Medical Science Monitor 2016; 22: 5003 doi: 10.12659/MSM.902177
|
32 |
Jian‐Gao Fan, Geoffrey C Farrell. VAT fat is bad for the liver, SAT fat is not!. Journal of Gastroenterology and Hepatology 2008; 23(6): 829 doi: 10.1111/j.1440-1746.2008.05474.x
|
33 |
Francesca M. Trovato, Giuseppe Fabio Martines, Daniela Catalano. Addressing Western dietary pattern in obesity and NAFLD. Nutrire 2018; 43(1) doi: 10.1186/s41110-018-0067-0
|
34 |
Elisa Fabbrini, Faidon Magkos. Treatment of the Obese Patient. 2014; : 121 doi: 10.1007/978-1-4939-1203-2_9
|
35 |
M. Snel, J. T. Jonker, J. Schoones, H. Lamb, A. de Roos, H. Pijl, J. W. A. Smit, A. E. Meinders, I. M. Jazet. Ectopic Fat and Insulin Resistance: Pathophysiology and Effect of Diet and Lifestyle Interventions. International Journal of Endocrinology 2012; 2012: 1 doi: 10.1155/2012/983814
|
36 |
Faidon Magkos. Exercise and fat accumulation in the human liver. Current Opinion in Lipidology 2010; 21(6): 507 doi: 10.1097/MOL.0b013e32833ea912
|
37 |
Dawn M. Torres, Stephen A. Harrison. Current treatments in nonalcoholic steatohepatitis. Current Treatment Options in Gastroenterology 2007; 10(6): 425 doi: 10.1007/s11938-007-0042-y
|
38 |
Yoichiro Kitajima, Yuichiro Eguchi, Eriko Ishibashi, Shunya Nakashita, Shigehisa Aoki, Shuji Toda, Toshihiko Mizuta, Iwata Ozaki, Naofumi Ono, Takahisa Eguchi, Kohei Arai, Ryuichi Iwakiri, Kazuma Fujimoto. Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease. Journal of Gastroenterology 2010; 45(2): 218 doi: 10.1007/s00535-009-0147-2
|
39 |
Alireza Ghaemi, Fourugh Azam Taleban, Azita Hekmatdoost, Alireza Rafiei, Vahid Hosseini, Zohreh Amiri, Reza Homayounfar, Hafez Fakheri. How Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease?. Hepatitis Monthly 2013; 13(12) doi: 10.5812/hepatmon.15227
|
40 |
Mariana Verdelho Machado, Helena Cortez-Pinto. Non-alcoholic fatty liver disease: What the clinician needs to know. World Journal of Gastroenterology 2014; 20(36): 12956-12980 doi: 10.3748/wjg.v20.i36.12956
|
41 |
Rustam N Karanjia, Mary M E Crossey, I Jane Cox, Haddy K S Fye, Ramou Njie, Robert D Goldin, Simon D Taylor-Robinson. Hepatic steatosis and fibrosis: Non-invasive assessment. World Journal of Gastroenterology 2016; 22(45): 9880-9897 doi: 10.3748/wjg.v22.i45.9880
|
42 |
Hong-Kyu Kim, Go-Eun Lee, Seong-Hoon Jeon, Jin-Ho Kim, Joong-Yeol Park, Ki-Up Lee, Chul-Hee Kim. Effect of Body Weight and Lifestyle Changes on Long-Term Course of Nonalcoholic Fatty Liver Disease in Koreans. The American Journal of the Medical Sciences 2009; 337(2): 98 doi: 10.1097/MAJ.0b013e3181812879
|
43 |
Ronald B Goldberg, Mark T Tripputi, Edward J Boyko, Matthew Budoff, Zsu-Zsu Chen, Jeanne M Clark, Dana M Dabelea, Sharon L Edelstein, Robert E Gerszten, Edward Horton, Kieren J Mather, Leigh Perreault, Marinella Temprosa, Amisha Wallia, Karol Watson, Zeb Irfan. Hepatic Fat in Participants With and Without Incident Diabetes in the Diabetes Prevention Program Outcome Study. The Journal of Clinical Endocrinology & Metabolism 2021; 106(11): e4746 doi: 10.1210/clinem/dgab160
|
44 |
Elke Roeb. MASLD – Prävention und ernährungsmedizinische
Behandlungsmöglichkeiten. Aktuelle Ernährungsmedizin 2023; 48(05): 362 doi: 10.1055/a-2145-0934
|
45 |
Somayyeh Asghari, Mahsa Rezaei, Maryam Rafraf, Mahdiyeh Taghizadeh, Mohammad Asghari-Jafarabadi, Maryam Ebadi. Effects of Calorie Restricted Diet on Oxidative/Antioxidative Status Biomarkers and Serum Fibroblast Growth Factor 21 Levels in Nonalcoholic Fatty Liver Disease Patients: A Randomized, Controlled Clinical Trial. Nutrients 2022; 14(12): 2509 doi: 10.3390/nu14122509
|
46 |
Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – April 2022 – AWMF Registration No.: 021–025. Zeitschrift für Gastroenterologie 2022; 60(09): e733 doi: 10.1055/a-1880-2388
|
47 |
Dawn M. Torres, Stephen A. Harrison. Diagnosis and Therapy of Nonalcoholic Steatohepatitis. Gastroenterology 2008; 134(6): 1682 doi: 10.1053/j.gastro.2008.02.077
|
48 |
W. Timothy Garvey, Jeffrey I. Mechanick, Elise M. Brett, Alan J. Garber, Daniel L. Hurley, Ania M. Jastreboff, Karl Nadolsky, Rachel Pessah-Pollack, Raymond Plodkowski. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity. Endocrine Practice 2016; 22: 1 doi: 10.4158/EP161365.GL
|
49 |
E. Roeb, A. Canbay, H. Bantel, J. Bojunga, J. de Laffolie, M. Demir, U. W. Denzer, A. Geier, W. P. Hofmann, C. Hudert, T. Karlas, M. Krawczyk, T. Longerich, T. Luedde, M. Roden, J. Schattenberg, M. Sterneck, A. Tannapfel, P. Lorenz, F. Tacke. Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025. Zeitschrift für Gastroenterologie 2022; 60(09): 1346 doi: 10.1055/a-1880-2283
|
50 |
Peter Dietrich, Claus Hellerbrand. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Practice & Research Clinical Gastroenterology 2014; 28(4): 637 doi: 10.1016/j.bpg.2014.07.008
|
51 |
E.L. Thomas, J.A. Fitzpatrick, S.J. Malik, S.D. Taylor-Robinson, J.D. Bell. Whole body fat: Content and distribution. Progress in Nuclear Magnetic Resonance Spectroscopy 2013; 73: 56 doi: 10.1016/j.pnmrs.2013.04.001
|
52 |
Romina Lomonaco, Janet Chen, Kenneth Cusi. An endocrine perspective of nonalcoholic fatty liver disease (NAFLD). Therapeutic Advances in Endocrinology and Metabolism 2011; 2(5): 211 doi: 10.1177/2042018811419157
|
53 |
Cilius Esmann Fonvig, Elizaveta Chabanova, Johanne Dam Ohrt, Louise Aas Nielsen, Oluf Pedersen, Torben Hansen, Henrik S. Thomsen, Jens-Christian Holm. Multidisciplinary care of obese children and adolescents for one year reduces ectopic fat content in liver and skeletal muscle. BMC Pediatrics 2015; 15(1) doi: 10.1186/s12887-015-0513-6
|
54 |
Kim-Anne Lê, Murielle Bortolotti. Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease. Current Opinion in Clinical Nutrition and Metabolic Care 2008; 11(4): 477 doi: 10.1097/MCO.0b013e328302f3ec
|
55 |
|
56 |
Helena Cortez-Pinto, Mariana Machado. Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2008; 2(2): 217 doi: 10.1586/17474124.2.2.217
|
57 |
Bubu A. Banini, Arun J. Sanyal. Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options. Clinical Medicine Insights: Therapeutics 2016; 8 doi: 10.4137/CMT.S18885
|
58 |
M. Pallayova, S. Taheri. Non‐alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies. Clinical Obesity 2014; 4(5): 243 doi: 10.1111/cob.12068
|
59 |
Elke Roeb. NAFLD – Prävention und ernährungsmedizinische
Behandlungsmöglichkeiten. Ernährung & Medizin 2022; 37(04): 167 doi: 10.1055/a-1917-8335
|
60 |
Ronald P Mensink, Jogchum Plat, Patrick Schrauwen. Diet and nonalcoholic fatty liver disease. Current Opinion in Lipidology 2008; 19(1): 25 doi: 10.1097/MOL.0b013e3282f382ea
|
61 |
M. K. OH, J. WINN, F. POORDAD. Review article: diagnosis and treatment of non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2008; 28(5): 503 doi: 10.1111/j.1365-2036.2008.03752.x
|
62 |
Sanjeev R Mehta, E Louise Thomas, Jimmy D Bell, Desmond G Johnston, Simon D Taylor-Robinson. Non-invasive means of measuring hepatic fat content. World Journal of Gastroenterology 2008; 14(22): 3476-3483 doi: 10.3748/wjg.14.3476
|
63 |
Milena Rundle, Jarlei Fiamoncini, E Louise Thomas, Suzan Wopereis, Lydia A. Afman, Lorraine Brennan, Christian A. Drevon, Thomas E. Gundersen, Hannelore Daniel, Isabel Garcia Perez, Joram M. Posma, Diana G. Ivanova, Jimmy D. Bell, Ben van Ommen, Gary Frost. Diet-induced Weight Loss and Phenotypic Flexibility Among Healthy Overweight Adults: A Randomized Trial. The American Journal of Clinical Nutrition 2023; 118(3): 591 doi: 10.1016/j.ajcnut.2023.07.002
|
64 |
Anish A. Patel, Dawn M. Torres, Stephen A. Harrison. Effect of Weight Loss on Nonalcoholic Fatty Liver Disease. Journal of Clinical Gastroenterology 2009; 43(10): 970 doi: 10.1097/MCG.0b013e3181b57475
|
65 |
Laurence Poekes, Vanessa Legry, Olivier Schakman, Christine Detrembleur, Anne Bol, Yves Horsmans, Geoffrey C. Farrell, Isabelle A. Leclercq. Defective adaptive thermogenesis contributes to metabolic syndrome and liver steatosis in obese mice. Clinical Science 2017; 131(4): 285 doi: 10.1042/CS20160469
|
66 |
Marieke Snel, Jacqueline T. Jonker, Sebastian Hammer, Gijs Kerpershoek, Hildo J. Lamb, A. Edo Meinders, Hanno Pijl, Albert de Roos, Johannes A. Romijn, Johannes W.A. Smit, Ingrid M. Jazet. Long‐Term Beneficial Effect of a 16‐Week Very Low Calorie Diet on Pericardial Fat in Obese Type 2 Diabetes Mellitus Patients. Obesity 2012; 20(8): 1572 doi: 10.1038/oby.2011.390
|
67 |
E. Louise Thomas, Gary Frost, Simon D. Taylor-Robinson, Jimmy D. Bell. Excess body fat in obese and normal-weight subjects. Nutrition Research Reviews 2012; 25(1): 150 doi: 10.1017/S0954422412000054
|
68 |
Nicola D. Guess, Anne Dornhorst, Nick Oliver, Jimmy D. Bell, E. Louise Thomas, Gary S. Frost. A randomized controlled trial: the effect of inulin on weight management and ectopic fat in subjects with prediabetes. Nutrition & Metabolism 2015; 12(1) doi: 10.1186/s12986-015-0033-2
|
69 |
Maya Balakrishnan, Kyle Liu, Sydney Schmitt, Natalia I. Heredia, Amy Sisson, Jane R. Montealegre, Ruben Hernaez, Fasiha Kanwal, John Foreyt. Behavioral weight-loss interventions for patients with NAFLD: A systematic scoping review. Hepatology Communications 2023; 7(8) doi: 10.1097/HC9.0000000000000224
|
70 |
Mariangela Morelli, Melania Gaggini, Giuseppe Daniele, Paolo Marraccini, Rosa Sicari, Amalia Gastaldelli. Ectopic fat: the true culprit linking obesity and cardiovascular disease?. Thrombosis and Haemostasis 2013; 110(10): 651 doi: 10.1160/TH13-04-0285
|
71 |
Zhen Cao, Lin-Ping Wu, Yun-Xia Li, Yu-Bo Guo, Yao-Wen Chen, Ren-Hua Wu. Change of choline compounds in sodium selenite-induced apoptosis of rats used as quantitative analysis by <italic>in vitro</italic> 9.4T MR spectroscopy. World Journal of Gastroenterology 2008; 14(24): 3891-3896 doi: 10.3748/wjg.14.3891
|
72 |
E L Thomas, A Makwana, R Newbould, A W Rao, G Gambarota, G Frost, B Delafont, R G Mishra, P M Matthews, E S Berk, S M Schwartz, J D Bell, J D Beaver. Pragmatic study of orlistat 60 mg on abdominal obesity. European Journal of Clinical Nutrition 2011; 65(11): 1256 doi: 10.1038/ejcn.2011.108
|
73 |
Arunima Pola, Suresh Anand Sadananthan, Venkatesh Gopalan, Min-Li Sandra Tan, Terry Yew Keong, Zhihong Zhou, Seigo Ishino, Yoshihide Nakano, Masanori Watanabe, Takashi Horiguchi, Tomoyuki Nishimoto, Bin Zhu, S. Sendhil Velan. Investigation of Fat Metabolism during Antiobesity Interventions by Magnetic Resonance Imaging and Spectroscopy. Magnetic Resonance Insights 2014; 7 doi: 10.4137/MRI.S19362
|
74 |
Effect of intensive weight-loss intervention on metabolic, ultrasound and anthropometric parameters among patients with obesity and non-alcoholic fatty liver disease: an RCT. European Journal of Clinical Nutrition 2022; 76(9): 1332 doi: 10.1038/s41430-022-01111-8
|
75 |
Juan P Arab, Roberto Candia, Rodrigo Zapata, Cristián Muñoz, Juan P Arancibia, Jaime Poniachik, Alejandro Soza, Francisco Fuster, Javier Brahm, Edgar Sanhueza, Jorge Contreras, M Carolina Cuellar, Marco Arrese, Arnoldo Riquelme. Management of nonalcoholic fatty liver disease: An evidence-based clinical practice review. World Journal of Gastroenterology 2014; 20(34): 12182-12201 doi: 10.3748/wjg.v20.i34.12182
|
76 |
R I Versteeg, M T Ackermans, A J Nederveen, E Fliers, M J Serlie, S E la Fleur. Meal timing effects on insulin sensitivity and intrahepatic triglycerides during weight loss. International Journal of Obesity 2018; 42(2): 156 doi: 10.1038/ijo.2017.199
|
77 |
Yasar Colak, Ilyas Tuncer, Ebubekir Senates, Oguzhan Ozturk, Levent Doganay, Yusuf Yilmaz. Nonalcoholic Fatty Liver Disease: A Nutritional Approach. Metabolic Syndrome and Related Disorders 2012; 10(3): 161 doi: 10.1089/met.2011.0145
|
78 |
S. Kaser, C. F. Ebenbichler, H. Tilg. Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease. International Journal of Clinical Practice 2010; 64(7): 968 doi: 10.1111/j.1742-1241.2009.02327.x
|
79 |
Megan ROSSI, Ingrid J. HICKMAN. Diet prescription for non‐alcoholic fatty liver disease: Is it worth the effort? A systematic review. Nutrition & Dietetics 2011; 68(1): 33 doi: 10.1111/j.1747-0080.2010.01486.x
|
80 |
Mathias Plauth, William Bernal, Srinivasan Dasarathy, Manuela Merli, Lindsay D. Plank, Tatjana Schütz, Stephan C. Bischoff. ESPEN guideline on clinical nutrition in liver disease. Clinical Nutrition 2019; 38(2): 485 doi: 10.1016/j.clnu.2018.12.022
|
81 |
Yoichiro Kitajima, Hideyuki Hyogo, Yoshio Sumida, Yuichiro Eguchi, Naofumi Ono, Takuya Kuwashiro, Kenichi Tanaka, Hirokazu Takahashi, Toshihiko Mizuta, Iwata Ozaki, Takahisa Eguchi, Yuki Kimura, Kazuma Fujimoto, Keizo Anzai. Severity of non‐alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle. Journal of Gastroenterology and Hepatology 2013; 28(9): 1507 doi: 10.1111/jgh.12227
|
82 |
Siôn A. Parry, Leanne Hodson. Managing NAFLD in Type 2 Diabetes: The Effect of Lifestyle Interventions, a Narrative Review. Advances in Therapy 2020; 37(4): 1381 doi: 10.1007/s12325-020-01281-6
|
83 |
Elisa Fabbrini, Faidon Magkos. Treatment of the Obese Patient. 2014; : 121 doi: 10.1007/978-1-4939-1203-2_9
|
84 |
Jing Qi, Yuman Fong, Leonard Saltz, Michael I. D'Angelica, Nancy E. Kemeny, Mithat Gonen, Jinru Shia, Amita Shukla‐Dave, William M. Jarnagin, Richard K. G. Do, Lawrence H. Schwartz, Jason A. Koutcher, Kristen L. Zakian. Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a 1H MRS study. NMR in Biomedicine 2013; 26(2): 204 doi: 10.1002/nbm.2837
|